Related Experiment Video
Updated: Nov 4, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.9K
Myocarditis combined with hypertrophic cardiomyopathy: a case report
Jing-Yue Wang1, Yu-Shi Wang1, Bo-Tao Shen1
1Department of Cardiology, The First Hospital of Jilin University, Changchun, China.
Annals of Palliative Medicine
|May 28, 2021
Summary
Persistent ventricular wall thickening in myocarditis patients may indicate coexisting hypertrophic cardiomyopathy (HCM). Early identification of this combination is crucial for appropriate patient management and treatment strategies.
Area of Science:
- Cardiology
- Infectious Diseases
- Genetics
Background:
- Myocarditis, an inflammation of the heart muscle, can lead to ventricular wall thickening due to edema.
- Persistent ventricular wall thickening, even after acute inflammation subsides, suggests an underlying condition.
- Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by abnormal thickening of the heart muscle.
Observation:
- A 30-year-old male presented with chest pain, sweating, and fever, initially improving with self-medication.
- ECG showed ST-segment elevation and ST-T wave changes; cardiac troponin I was markedly elevated.
- Echocardiography revealed significant interventricular septum thickening (17 mm) and left ventricular hypokinesia, without outflow tract obstruction.
Findings:
- Laboratory tests were negative for respiratory infections but positive for IgG antibodies against herpes simplex virus (HSV), rubella virus (RV), and cytomegalovirus (CMV).
- The patient was diagnosed with myocarditis coexisting with hypertrophic cardiomyopathy (HCM).
- Persistent ventricular wall thickening in the context of myocarditis is a key indicator for considering concomitant HCM.
Implications:
- This case highlights the importance of considering hypertrophic cardiomyopathy (HCM) in patients with myocarditis presenting with persistent ventricular wall thickening.
- Prompt diagnosis and management of combined myocarditis and HCM are essential to prevent adverse cardiovascular outcomes.
- Further research into the interplay between viral infections and genetic predispositions in developing combined cardiac conditions is warranted.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
113
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
113
01:21Myocarditis I: Introduction
123
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
123
01:27Myocarditis II: Clinical Features and Diagnostic Tests
70
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
70
01:29Cardiomyopathy V: Interprofessional Care
96
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
96
01:14Myocarditis III: Medical Management
44
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
44
01:30Cardiomyopathy II: Dilated Cardiomyopathy
114
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114